Ectopic EBV Infection in T Cells Identifies Reduced Therapeutic Responsiveness and Immune Dysfunction after Allogeneic Hematopoietic Stem Cell Transplantation (ICBMT 2026) - Oct 8, 2026 - Abstract #OP03-2; Pres time: Sep 17, 2026; 09:10 AM - 09:20 AM; Location: Room C(2F); "These findings suggest that T-cell EBV quantification distinguishes a therapeutically challenging subtype of EBV reactivation characterized by immune dysfunction and reduced responsiveness to rituximab-based therapy. Incorporating assessment of cellular viral reservoirs into post-transplant EBV monitoring strategies may facilitate early risk stratification and support timely therapeutic escalation beyond rituximab alone. Keywords: Epstein-Barr virus, Post-Transplant Lymphoproliferative Disorder, T-cell Tropic EBV Infection, Allogeneic Hematopoietic Stem Cell Transplantation"
Bone Marrow Transplantation • Epstein-Barr Virus Infections • Infectious Disease • Transplantation • CD20
|
|
Zhifan Zhao 1; Xuying Pei 1
|